| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.0M | +177.9% |
| R&D Expense | $145.4M | +28.4% |
| SG&A Expense | $49.1M | -2.6% |
| Operating Income | -$159.5M | -5.6% |
| Pre-tax Income | -$120.3M | -10.4% |
| Income Tax | $14.1M | +289.6% |
| Net Income | -$134.4M | -19.3% |
| EPS (Basic) | -$3.32 | -5.4% |
| EPS (Diluted) | -$3.32 | -5.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.1M | -43.4% |
| Short-term Investments | $352.5M | +25.6% |
| Current Assets | $509.5M | -7.5% |
| Total Assets | $687.0M | +2.9% |
| Current Liabilities | $40.4M | +0.9% |
| Total Liabilities | $96.7M | +4.7% |
| Stockholders' Equity | $590.3M | +2.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.2M | +5.4% |
| Capital Expenditures | $1.6M | -44.9% |
| Investing Cash Flow | -$131.2M | -280.5% |
| Financing Cash Flow | $122.2M | — |
| Free Cash Flow | -$99.8M | +6.5% |